News from the ESC Congress 2017

Letter to Readers |
August 30, 2017

News from the ESC Congress 2017

NEJM Journal Watch and Physician's First Watch coverage of the meeting

This week, NEJM Journal Watch and Physician's First Watch have brought you coverage of study findings presented at the European Society of Cardiology's annual 2017 meeting in Barcelona, Spain. Here is a compilation of our coverage, listed by date and title of meeting presentations, with the articles' first authors in parentheses.

(Your NEJM Journal Watch subscription is required, except where noted.)

Tuesday, August 29, 2017

Clinical Effects of Anacetrapib in People with Established Vascular Disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55–REVEAL) trial (The HPS3/TIMI55–REVEAL Collaborative Group)

NEJM Journal Watch coverage

Dietary Fats Are Protective but Carbohydrates Are Harmful: First Results of the PURE Nutrition Study on 135,000 People from 18 Countries in 5 Continents (Dehghan M et al.)

Physician's First Watch coverage (free)

Monday, August 28, 2017

SPYRAL HTN OFF-MED Study (Townsend RR et al.)

NEJM Journal Watch coverage

DETermination of the Role of OXygen in Suspected Acute Myocardial Infarction (Hofmann R et al.)

NEJM Journal Watch coverage (free)

A Naturally Randomized Trial Comparing the Effect of Genetic Variants That Mimic CETP Inhibitors and Statins on the Risk of Cardiovascular Disease (Ference BA et al.)

NEJM Journal Watch coverage

Sunday, August 27, 2017

CANTOS: The Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (Ridker PM et al.)

NEJM Journal Watch coverage (free)

Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial: Primary Results (Eikelboom JW et al.)

NEJM Journal Watch coverage (free)

The Bivalirudin Versus Heparin in Non-ST and ST-Segment Elevation Myocardial Infarction in Patients on Modern Antiplatelet Therapy in SWEDEHEART (Erlinge D et al.)

NEJM Journal Watch coverage (free)

RE-DUAL PCI: Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation (Cannon CP et al.)

NEJM Journal Watch coverage (free)

Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes — TROPICAL-ACS — Trial (Sibbing D et al.)

NEJM Journal Watch coverage

Saturday, August 26, 2017

BIOFLOW-V: A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With Up to Three De Novo or Restenotic Coronary Artery Lesions (Kandzari DE et al.)

NEJM Journal Watch coverage

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.